This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Safety and Efficacy Study of the Z-Lig Medical Device Compared to Allograft (Z-Lig)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2014 by Aperion Biologics, Inc..
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Aperion Biologics, Inc.
ClinicalTrials.gov Identifier:
NCT01245400
First received: November 1, 2010
Last updated: March 11, 2014
Last verified: March 2014
  Purpose
The purpose of this Trial is to demonstrate the safety and efficacy of the Investigational Device for the treatment of ruptured Anterior Cruciate Ligament (ACL) of the knee compared to Allograft.

Condition Intervention
Ruptured Anterior Cruciate Ligaments Device: Z-Lig Device: allograft

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments

Resource links provided by NLM:


Further study details as provided by Aperion Biologics, Inc.:

Primary Outcome Measures:
  • KT-1000 [ Time Frame: baseline, 3,6, 12 & 24 monhts ]
    Contact Sponsor


Estimated Enrollment: 60
Study Start Date: November 2010
Estimated Study Completion Date: April 2017
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Z-Lig
Z-Lig Anterior Cruciate Ligament Reconstruction (ACLR) graft implantation performed under anesthesia during an arthroscopic procedure.
Device: Z-Lig
ACL replacement
Active Comparator: Allograft
Allograft bone/tendon graft implantation performed under anesthesia during an arthroscopic procedure.
Device: allograft
ACL replacement

Detailed Description:

Current techniques to reconstruct ruptured ACLs utilize either autologous tissue or allograft (cadaver) tissue. Both treatments have well-documented shortcomings (i.e., autologous tissue exposes patients to increased morbidity and allograft tissue use is limited by global availability and quality).

There are currently no effective artificial materials or xenograft tissue substitutes widely available. The purpose of this multicenter clinical trial is to evaluate the safety and efficacy of the Z-Lig in Subjects who require reconstruction of primary ruptured anterior cruciate ligaments and compare those results to allograft.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
Contact Sponsor
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01245400

Locations
Belgium
Contact Sponsor, Belgium
Denmark
Contact Sponsor, Denmark
Italy
Bologna, Italy
Netherlands
Contact Sponsor, Netherlands
South Africa
Contact Sponsor, South Africa
Spain
Contact Sponsor, Spain
Sponsors and Collaborators
Aperion Biologics, Inc.
  More Information

Additional Information:
Responsible Party: Aperion Biologics, Inc.
ClinicalTrials.gov Identifier: NCT01245400     History of Changes
Other Study ID Numbers: ABI-ZLig-01-10-01
Study First Received: November 1, 2010
Last Updated: March 11, 2014

Keywords provided by Aperion Biologics, Inc.:
Z-Lig
allograft
ACL
Anterior Cruciate Ligament
ACLR
Anterior Cruciate Ligament Reconstruction
EU
European Union
S. Africa
Reconstruction of ruptured anterior cruciate ligaments

Additional relevant MeSH terms:
Rupture
Wounds and Injuries

ClinicalTrials.gov processed this record on September 21, 2017